Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 7/20 | 0.53 |
| ▸ | IDO1 | P14902 | 6/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | G6PD | P11413 | 1/20 | 0.49 |
| ▸ | EP300 | Q09472 | 2/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.47 |
| ▸ | CDC25B | P30305 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8931188 | 0.78 | IDO1 (0.68) | IDO1EP300KAT2BKAT8CDC25B | |
| SCHEMBL11840391 | 0.77 | IDO1 (0.58) | IDO1MEN1KMT2AMAP1LC3BGAA | |
| SCHEMBL20483185 | 0.77 | RAPGEF4 (0.58) | RAPGEF4 | |
| SCHEMBL18351203 | 0.76 | RAPGEF4 (0.61) | RAPGEF4MEN1KMT2AGAACDC25B | |
| SCHEMBL2199650 | 0.76 | RAPGEF4 (0.70) | RAPGEF4 | |
| SCHEMBL28194328 | 0.75 | CYP1A2 (0.53) | RAPGEF4IDO1MEN1KMT2A | |
| SCHEMBL13140103 | 0.74 | RAPGEF4 (0.63) | RAPGEF4MEN1KMT2A | |
| SCHEMBL25287525 | 0.74 | MEN1 (0.71) | MEN1KMT2AMAP1LC3BGAAG6PD | |
| SCHEMBL25791942 | 0.74 | MEN1 (0.47) | IDO1MEN1KMT2AMAP1LC3BGAA | |
| SCHEMBL21165036 | 0.74 | RAPGEF4 (0.47) | RAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351526-B2 | Coloring curable resin composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, image display device, compound, and cation | FUJIFILM CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-3947471-A | CHROMOGENIC | SUMITOMO CHEMICAL COMPANY, LTD. (JA) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351526-B2 | Coloring curable resin composition, cured film, color filter, method for manufacturing color filter, solid-state imaging device, image display device, compound, and cation | O60361, WDR12, SEM1 | RAPGEF4 3390/4885IDO1 3157/4885MEN1 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.